4031 - 4040 of 7665 Results
Title
Year
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
-
RESTRICTEDTitle: Fractures in the prodromal period of Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000009452Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455361Citation Count: 10
- “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation2020RESTRICTEDTitle: “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial ParticipationJournal Name: AJOB Empirical BioethicsPublisher: Informa UK LimitedVol: 11Issue #: 3Start Page: 160End Page: 171Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/23294515.2020.1775721Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212889Citation Count: 5
- Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease2020RESTRICTEDTitle: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66319-9Best OA location URL: https://www.nature.com/articles/s41598-020-66319-9.pdfCitation Count: 19
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 14Issue #: 6Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866Best OA location URL: https://ndownloader.figstatic.com/files/22969427Citation Count: 10
- Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists2020RESTRICTEDTitle: Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonistsJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 3361End Page: 3363Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-020-04501-7Citation Count: 1
- Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease2020RESTRICTEDTitle: Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00161Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.00161/pdfCitation Count: 22
- Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face Validity2020RESTRICTEDTitle: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face ValidityJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 11Start Page: 3216End Page: 3216Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20113216Best OA location URL: https://www.mdpi.com/1424-8220/20/11/3216/pdf?version=1591769863Citation Count: 21
- Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure Hydrocephalus2020RESTRICTEDTitle: Association Between Cerebrospinal Fluid Biomarkers and Age-related Brain Changes in Patients with Normal Pressure HydrocephalusJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66154-yBest OA location URL: https://www.nature.com/articles/s41598-020-66154-y.pdfCitation Count: 13